Pharmacy First income: the short answer
Pharmacy First income is a growing, separately accounted revenue line under the NHS Community Pharmacy Contractual Framework. It has its own fee structure and thresholds, and it is paid as a remuneration fee, not as a Drug Tariff reimbursement. It must be booked as a distinct line in your management accounts. Merging it into a single NHS income total means you cannot see how it is performing, cannot benchmark it, and cannot manage it. The short rule: dispensing reimbursement and service income are two different things, and your accounts should show both.
Where NHS service income sits in your income
Pharmacy income is contract-driven, not till-driven. Under the Community Pharmacy Contractual Framework, income has two broad components:
- Reimbursement, which covers the ingredient cost of dispensed medicines at Drug Tariff prices. The pharmacy recovers what it paid for the drugs, adjusted by Category M and other price mechanisms.
- Remuneration, which covers fees and service payments. This includes the essential and advanced service payments that sit alongside dispensing, and it is where Pharmacy First income sits.
This distinction matters because the two components behave differently, are calculated differently, and are paid under different mechanisms. Treating total NHSBSA receipts as a single number collapses that structure and leaves you without the information you need to understand your own business.
Why service income is a separate revenue line
Pharmacy First and similar NHS enhanced services are a growing part of the remuneration side of pharmacy income. For many pharmacies, service income was a small rounding error five years ago. It is no longer that. As the volume of Pharmacy First consultations increases and the range of commissioned services widens, the service income line has grown in both absolute size and in its share of total NHS income.
Service income has its own fee structure and thresholds, distinct from the Drug Tariff arithmetic that sets dispensing reimbursement. It is paid per service provided or per claim submitted, not as a reimbursement of ingredient cost. The two income streams respond to different levers: dispensing volume, product mix and Drug Tariff movements drive reimbursement; consultation volume and service delivery drive service income.
Keeping them on separate lines is not a bookkeeping preference. It is the only way to see which is growing, which is under pressure, and where management attention belongs.
How the fee structure differs from dispensing
| Feature | Dispensing reimbursement | NHS service income (Pharmacy First and similar) |
|---|---|---|
| What it pays for | Ingredient cost of dispensed medicines | Clinical services provided under commission |
| How it is calculated | Drug Tariff prices, Category M, endorsements | Fee per service or per claim, under its own fee structure |
| What drives volume | Prescription volume and product mix | Consultation volume and commissioned service scope |
| Payment cycle | FP34 monthly submission, payment roughly two months later with an advance on account | Paid under the CPCF payment schedule; reconcile claims submitted against payments received |
| VAT treatment | Zero-rated (dispensing by registered pharmacist against prescription) | Can be exempt or standard-rated depending on the service; must be mapped separately (see VAT note below) |
| CPCF source | CPCF reimbursement schedule | CPCF remuneration schedule |
The key point on the fee structure: the specific fee rates for Pharmacy First are set by NHS England and published on the Pharmacy First service page. This post does not restate those figures because they are subject to contract updates. What matters for the accounts is that the structure exists, that it is separate from Drug Tariff arithmetic, and that your bookkeeping reflects that separation.
How it books versus dispensing income
The practical accounting split is straightforward. In a well-structured set of pharmacy management accounts, the income section shows at minimum:
- Dispensing reimbursement: the Drug Tariff recovery for ingredient costs, reconciled against FP34 submissions.
- NHS service income: Pharmacy First and other commissioned service fees, reconciled against claims submitted and NHSBSA payment statements.
- OTC retail and private sales: standard-rated counter sales, tracked separately because the VAT treatment differs from both lines above.
Some pharmacies add a fourth line for private services (private travel health, private prescriptions and so on) where that income is material. The point is not that there must be exactly three lines; it is that lumping any two together loses the management information each line carries.
Reconciliation works differently for each line. Dispensing reimbursement is reconciled by matching FP34 submissions to the NHSBSA payment schedule, tracking the two-month lag and the advance on account (see the how the FP34 payment cycle works post for the cash-flow mechanics). Service income is reconciled by matching claims submitted for Pharmacy First consultations against the remuneration payments that follow. These are separate reconciliation processes, and running them together creates errors in both.
The VAT question, briefly
Dispensing is zero-rated under VAT Notice 701/57. Service income is not automatically zero-rated: services supplied by pharmacists can be exempt or standard-rated, and the treatment depends on the nature of the service. This is a material distinction for input VAT recovery and for the pharmacy's partial exemption position. The accounting and VAT treatment of NHS service income is covered in detail in the VAT on private services and Pharmacy First income post.
Why tracking it separately is a management-accounting job
The management-accounting case for separate tracking is simple: you cannot benchmark or grow a line you cannot see.
Service income as a share of total NHS income varies significantly across pharmacies. Some are early in delivering Pharmacy First; others are running it at high volume. Without a separate line in the accounts, a pharmacy owner cannot answer basic questions about their own business: Is service income growing? At what rate? How does it compare with pharmacies of similar dispensing volume? Is the consultation capacity being used efficiently?
These questions feed directly into margin analysis. A pharmacy that combines reimbursement and service income into one number cannot separate the margin behaviour of each. Dispensing margin is driven by Drug Tariff mechanics and Category M movements. Service income margin is driven by the cost of delivering the service (staff time, consumables, capacity). The two are managed differently, and mixing them obscures both.
Benchmarking also depends on clean income lines. Cross-pharmacy comparisons are only valid when the same definitions are used. Mixing income types produces comparisons that are not like-for-like and can mask real performance gaps or strengths.
Getting your NHS income lines right
The first step is making sure your chart of accounts has the right income categories. If your accounts currently show a single NHS income line, separating dispensing reimbursement from service income is a one-time restructuring exercise that pays for itself in the clarity it creates.
The second step is building reconciliation routines that match each income line to the correct NHSBSA statements and payment schedules. This is not the same process for each line, and trying to run one reconciliation across both creates errors.
The third step is using the separated lines for benchmarking. If you are comparing your pharmacy against sector averages or against your own prior periods, the comparison is only useful if the definitions match. A benchmarking exercise that mixes income types produces numbers that are not comparable with anything.
Pharmacy income structure is more complex than most sectors, and generalist accountants frequently miss the service income separation entirely. If your current accounts do not reflect the distinction between dispensing reimbursement and service income, the pharmacy benchmarking and margin analysis service is the right starting point: it structures the income lines correctly, runs the reconciliations, and gives you the benchmarks to see where each line is performing relative to similar pharmacies.
England only. The CPCF, Drug Tariff and Pharmacy First framework described here is the England NHS contract. Scotland, Wales and Northern Ireland operate under different contract arrangements. If your pharmacy operates outside England, the income structure and fee frameworks will differ.